Welcome to The Human Data Era, a special edition podcast series produced by The Scientist’s Creative Services Team.
This series is brought to you by Amgen, a pioneer in the science of using living cells to make biologic medicines. They helped invent the processes and tools that built the global biotech industry, and have since reached millions of patients suffering from serious illnesses around the world with their medicines.
By studying human genetics, scientists discovered mechanisms that, when defective, cause disease. While this type of data is powerful, additional information can provide more insight on the human condition. Researchers and clinicians can now go beyond genetics, combining proteomics, metabolomics, transcriptomics, and environmental factors into a broad category of human data. In this series, Ray Deshaies, senior vice president of Global Research at Amgen, explores the potential of human data and the important transition scientists and clinicians are making to incorporate this wealth of information into drug research and development.
Sign up now to receive an email when each podcast episode airs.
- Episode 1 - Human Data: Beyond the Genome
October 20, 2022 - Episode 2 - New Connections Between Genetics and Human Disease
October 27, 2022 - Episode 3 - Exploring Human Data in Cardiovascular Disease
November 3, 2022 - Episode 4 - The Role of Human Diversity in Progressing Precision Medicine
November 10, 2022
Visit this page to sign up for The Human Data Era Q&A event, airing soon!
Host
 | Ray Deshaies, PhD Senior Vice President Global Research Amgen |